1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1antagonistic activity

Details for Australian Patent Application No. 2002337106 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Herremans, Arnoldus H.J.; Van Stuivenberg, Herman H.; Lange, Josephus H.M.; Kruse, Cornelis G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002337106

PCT Number PCT/EP02/10434

PCT Pub. Number WO2003/027076

Priority 01203851.9 21.09.01 EP

Filing date 17 September 2002

Wipo publication date 7 April 2003

Acceptance publication date 17 May 2007

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/12 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 Drugs for disorders of the nervous system

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 01203851.9 21.09.01 EP

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002337106

17 May 2007 Application Accepted

  Published as AU-B-2002337106

13 September 2007 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002337107-3-`HYDROXY-(-4-TRIFLUOROMETHY LPHENYL)-METHYL-7-SPIROCYCLO BUTYL5,6,7,8-TETRAHYDROQUINOLIN-5-OL DERIVATIVES AND THE USE OF THE SAME AS CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) INHIBITORS

2002337105-Combination of a NSAID and a PDE-4 inhibitor